Dr. Dan Brat interviewed on Northwestern Feinberg School of Medicine Podcast

In the latest episode of theNorthwestern Medicine Breakthroughs podcast,Daniel Brat, MD, PhD discusses the emerging integrated molecular-histomorphological classification of diffuse gliomas. In an episode entitled " A New Way to Diagnose Brain Tumors " , Dr. Brat -- the new chairman of theNorthwestern Pathology -- states that "whenever you go through a reclassification that dramatic, there ' s going to be gaps in knowledge and gaps in practice and we are recognizing those gaps on aDr. Dan Bratdaily basis, on a yearly basis.  And we as a brain tumor community internationally are working to fill those gaps in knowledge. So what we found for example, is that once you classify molecular diseases, thegrading criteria that we used in the past to grade things as [World Health Organization] grade one, grade two, grade three, grade four, which really served to predict how patients are going to fair and what type of therapies they are going to need, all of those grading criteria needed to be recalibrated. And that ' s a significant undertaking as well. And we have certain initiatives within the international community through an organization calledcIMPACT-Now [Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy – Not Official WHO]. And we as a group, including some colleagues here atNorthwestern Feinberg School of Medicine, are writing the guidelines for new grading criteria for the diffuse gliomas within the molecular era. " . Thepodcast aire...
Source: neuropathology blog - Category: Radiology Tags: neuropathologists Source Type: blogs